Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157029763> ?p ?o ?g. }
- W3157029763 endingPage "e3001221" @default.
- W3157029763 startingPage "e3001221" @default.
- W3157029763 abstract "Premature termination codons (PTC) cause over 10% of genetic disease cases. Some aminoglycosides that bind to the ribosome decoding center can induce PTC readthrough and restore low levels of full-length functional proteins. However, concomitant inhibition of protein synthesis limits the extent of PTC readthrough that can be achieved by aminoglycosides like G418. Using a cell-based screen, we identified a small molecule, the phenylpyrazoleanilide Y-320, that potently enhances TP53 , DMD , and C OL17A1 PTC readthrough by G418. Unexpectedly, Y-320 increased cellular protein levels and protein synthesis, measured by SYPRO Ruby protein staining and puromycin labeling, as well as ribosome biogenesis measured using antibodies to rRNA and ribosomal protein S6. Y-320 did not increase the rate of translation elongation and it exerted its effects independently of mTOR signaling. At the single cell level, exposure to Y-320 and G418 increased ribosome content and protein synthesis which correlated strongly with PTC readthrough. As a single agent, Y-320 did not affect translation fidelity measured using a luciferase reporter gene but it enhanced misincorporation by G418. RNA-seq data showed that Y-320 up-regulated the expression of CXC chemokines CXCL10, CXCL8, CXCL2, CXCL11, CXCL3, CXCL1, and CXCL16. Several of these chemokines exert their cellular effects through the receptor CXCR2 and the CXCR2 antagonist SB225002 reduced cellular protein levels and PTC readthrough in cells exposed to Y-320 and G418. These data show that the self-limiting nature of PTC readthrough by G418 can be compensated by Y-320, a potent enhancer of PTC readthrough that increases ribosome biogenesis and protein synthesis. They also support a model whereby increased PTC readthrough is enabled by increased protein synthesis mediated by an autocrine chemokine signaling pathway. The findings also raise the possibility that inflammatory processes affect cellular propensity to readthrough agents and that immunomodulatory drugs like Y-320 might find application in PTC readthrough therapy." @default.
- W3157029763 created "2021-05-10" @default.
- W3157029763 creator A5022942164 @default.
- W3157029763 creator A5027814868 @default.
- W3157029763 creator A5042361937 @default.
- W3157029763 creator A5062355115 @default.
- W3157029763 creator A5075759028 @default.
- W3157029763 creator A5084792106 @default.
- W3157029763 date "2021-05-03" @default.
- W3157029763 modified "2023-09-24" @default.
- W3157029763 title "Small molecule Y-320 stimulates ribosome biogenesis, protein synthesis, and aminoglycoside-induced premature termination codon readthrough" @default.
- W3157029763 cites W1909637030 @default.
- W3157029763 cites W1968075505 @default.
- W3157029763 cites W1972281096 @default.
- W3157029763 cites W1974935001 @default.
- W3157029763 cites W1988501412 @default.
- W3157029763 cites W1992486617 @default.
- W3157029763 cites W1996436013 @default.
- W3157029763 cites W1999999605 @default.
- W3157029763 cites W2002751898 @default.
- W3157029763 cites W2006637048 @default.
- W3157029763 cites W2009601727 @default.
- W3157029763 cites W2010032123 @default.
- W3157029763 cites W2010534652 @default.
- W3157029763 cites W2011452661 @default.
- W3157029763 cites W2013126678 @default.
- W3157029763 cites W2035363248 @default.
- W3157029763 cites W2036699425 @default.
- W3157029763 cites W2054452976 @default.
- W3157029763 cites W2061361190 @default.
- W3157029763 cites W2065437076 @default.
- W3157029763 cites W2066841033 @default.
- W3157029763 cites W2071226544 @default.
- W3157029763 cites W2071895752 @default.
- W3157029763 cites W2073717776 @default.
- W3157029763 cites W2074477570 @default.
- W3157029763 cites W2083734806 @default.
- W3157029763 cites W2085811948 @default.
- W3157029763 cites W2087070256 @default.
- W3157029763 cites W2087812126 @default.
- W3157029763 cites W2101932766 @default.
- W3157029763 cites W2114534925 @default.
- W3157029763 cites W2114995688 @default.
- W3157029763 cites W2117617781 @default.
- W3157029763 cites W2118082232 @default.
- W3157029763 cites W2126330038 @default.
- W3157029763 cites W2129585918 @default.
- W3157029763 cites W2137108719 @default.
- W3157029763 cites W2140771002 @default.
- W3157029763 cites W2156697631 @default.
- W3157029763 cites W2158389310 @default.
- W3157029763 cites W2164401185 @default.
- W3157029763 cites W2164428603 @default.
- W3157029763 cites W2171710012 @default.
- W3157029763 cites W2463975511 @default.
- W3157029763 cites W2586779720 @default.
- W3157029763 cites W2730585910 @default.
- W3157029763 cites W2770893462 @default.
- W3157029763 cites W2773619385 @default.
- W3157029763 cites W2774536896 @default.
- W3157029763 cites W2801716685 @default.
- W3157029763 cites W2900665650 @default.
- W3157029763 cites W2940212459 @default.
- W3157029763 cites W2945633067 @default.
- W3157029763 cites W3011124433 @default.
- W3157029763 cites W3017856136 @default.
- W3157029763 cites W4237534021 @default.
- W3157029763 doi "https://doi.org/10.1371/journal.pbio.3001221" @default.
- W3157029763 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8118496" @default.
- W3157029763 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33939688" @default.
- W3157029763 hasPublicationYear "2021" @default.
- W3157029763 type Work @default.
- W3157029763 sameAs 3157029763 @default.
- W3157029763 citedByCount "6" @default.
- W3157029763 countsByYear W31570297632021 @default.
- W3157029763 countsByYear W31570297632022 @default.
- W3157029763 countsByYear W31570297632023 @default.
- W3157029763 crossrefType "journal-article" @default.
- W3157029763 hasAuthorship W3157029763A5022942164 @default.
- W3157029763 hasAuthorship W3157029763A5027814868 @default.
- W3157029763 hasAuthorship W3157029763A5042361937 @default.
- W3157029763 hasAuthorship W3157029763A5062355115 @default.
- W3157029763 hasAuthorship W3157029763A5075759028 @default.
- W3157029763 hasAuthorship W3157029763A5084792106 @default.
- W3157029763 hasBestOaLocation W31570297631 @default.
- W3157029763 hasConcept C104202773 @default.
- W3157029763 hasConcept C104317684 @default.
- W3157029763 hasConcept C105580179 @default.
- W3157029763 hasConcept C149364088 @default.
- W3157029763 hasConcept C153911025 @default.
- W3157029763 hasConcept C185592680 @default.
- W3157029763 hasConcept C2779200571 @default.
- W3157029763 hasConcept C2779419633 @default.
- W3157029763 hasConcept C2780926556 @default.
- W3157029763 hasConcept C3675279 @default.
- W3157029763 hasConcept C55493867 @default.
- W3157029763 hasConcept C62478195 @default.
- W3157029763 hasConcept C67705224 @default.